Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Clinical trial NCT01305408 · COMPLETED
Trial details
- NCT number
- NCT01305408
- Sponsor
- Cephalon
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2013-07-01
- Enrollment
- 399
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.